MSK-ACCESS powered with SOPHiA DDM - Brochure

Push the boundaries of your in-house liquid biopsy capabilities with MSK-ACCESS® powered with SOPHiA DDM™, a decentralized version of the rigorously validated cell-free DNA (cfDNA) assay developed and regularly used in clinical routine by Memorial Sloan Kettering Cancer Center (MSK)1,2.